Here are some companies that are making headlines in intraday trading. Carnival — Carnival shares rose 12% after the cruise company reported third-quarter profits that beat Wall Street expectations before the market opened. Management reported that bookings were strong despite the macro challenges facing consumers, noting that calendar year 2027 was booked at record occupancy rates, while occupancy rates and prices for 2028 were also higher year-over-year. Shares of Royal Caribbean and Norwegian Cruise Line also rose in line, rising 6% and about 4%, respectively. Ivans Biotherapeutics — Shares rose 26% after the cancer treatment-focused biotechnology company raised its full-year earnings outlook. Iovance’s revenue increased from $350 million to $370 million previously to $410 million to $420 million. Bloom Energy — Shares rose 13%. Jefferies kept its rating unchanged but raised its price target from $229 to $264, citing the energy company’s growth prospects. Additionally, the city of Fremont, Calif., posted on LinkedIn Friday that Bloom Energy has acquired a 158,000-square-foot facility for expansion. Artificial intelligence in action — Stock prices associated with AI-building efforts rose as investors bought up stocks. Lumentum’s share price rose 6%, while Nevius Group’s share price rose 4%. Coreweave stock rose nearly 2%. Oracle — The database management platform’s stock rose more than 5%. Oracle has debuted Fusion Claw, an agent application that “combines AI inference and deterministic enterprise calculations to enable highly complex tasks to be completed economically and at scale,” the company said in a statement. Fair Isaac — Shares fell 18% after Federal Housing Finance Agency Commissioner Bill Pruitt introduced mortgage pricing changes. “In response to feedback from lenders and consumers, we are simplifying mortgage pricing. Instead of two separate pricing grids that make no sense at all, Fannie and Freddie are adding VantageScore to the existing FICO Classic pricing grid. We are moving to a single pricing grid with the addition of…” Pulte said in a post on X. Bloomin’ Brands — shares of parent company Outback Steakhouse rose 3% after J.P. Morgan upgraded the company to neutral from underweight. The bank pointed to several changes the restaurant chain has implemented, including a new steak lineup and “reducing the table-to-server ratio from six tables to four tables during peak hours.” SpaceX — Shares rose 2% after TD Cowen initiated research coverage on the space company with a buy rating. Analysts pointed to growth in artificial intelligence and space exploration as SpaceX’s main drivers. Summit Therapeutics — Shares rose 5% after the drugmaker announced a $2 billion investment from AstraZeneca. “Summit has entered into an agreement with AstraZeneca for a strategic equity investment in Summit and a clinical collaboration focused on ivonecicimab and sonecitag vedotin (sone-ve),” Summit said in a release. Ibonecimab and Sonesitag Vedotin are drugs intended to treat cancer. CarMax — Shares rose more than 5% after the used car retailer reported better-than-expected second-quarter results. CarMax earned $1.16 per share on revenue of $7.88 billion. Analysts polled by FactSet expected revenue of $7.09 billion and earnings of 73 cents a share. —CNBC’s Nick Wells, Michelle Fox, Paulina Ricos, Scott Schnipper and Darla Mercado contributed reporting.
